Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Erythroblastic sarcoma transformation from chronic myeloid leukaemia: A case report

Nagah Elmusharaf, Mohammed Abdelsalam, Mohammed Alghamdi, Ayman Mahmoud, Nouf Albalawi, Ahmed Alrajjal, Hayder Abdulwahid, Abdul Muqtadir Abbasi, BADR ALJOAID, Adel Alnakhli, Mohammed Almakadi, Amal Albeihany, Zeyad Alshaibani

Blood (2025) 146 (Supplement 1): 7309.

https://doi.org/10.1182/blood-2025-7309

Published: 2025

Journal Articles

Conventional Versus Condensed Regimen of High Dose Cytarabine Consolidation in Acute Myeloid Leukemia

Abdullah M Alrajhi, Jude Howaidi, Adel Alnakhli, Fouad H. Alnajjar, Mansour Alfayez

Blood (2022) 140 (Supplement 1): 11729–11730.

https://doi.org/10.1182/blood-2022-166355

Published: 2022

Journal Articles

Polatuzumab Vedotin As a Salvage Treatment in Relapsed or Refractory DLBCL: Single Center Experience

Marwa Bin Morya, Mohammed A. Marei, Imran K. Tailor, Abdullah M Alrajhi, Adel Alnakhli, Foud Alnajjar, Mohammed S. Alnoamani, Hassan Alshehri, Ibraheem H. Motabi, Nawal AlShehry, Mansour Alfayez

Blood (2021) 138 (Supplement 1): 4558.

https://doi.org/10.1182/blood-2021-150242

Published: 2021

Journal Articles

Safety and Efficacy of Azacitidine with Venetoclax for Newly Diagnosed Intensive Chemotherapy Ineligible, and Relapsed or Refractory Acute Myeloid Leukemia in Arab Population: A Single-Center, Retrospective Study

Mohammmad Alwadi, Jude Howaidi, Abdullah M Alrajhi, Adel Alnakhli, Mohammed A. Marei, Imran K. Tailor, Fouad H. Alnajjar, Syed Y. Altaf, Mohammed S. Alnoamani, Kamal Alzahrani, Hassan Alshehri, Ibraheem H. Motabi, Syed Ziauddin A Zaidi, Nawal F Alshehry, Mansour Alfayez

Blood (2021) 138 (Supplement 1): 4423.

https://doi.org/10.1182/blood-2021-153335

Published: 2021

Journal Articles

Efficacy of Brentuximab Vedotin and Bendamustine Combination in Relapsed/Refractory Hodgkin Lymphoma: Experience from a Tertiary Care Hospital

Abdullah M Alrajhi, Razan A. Aljalali, Lara H. Alghazi, Ibrahim Asiri, Adel Alnakhli, Fouad H. Alnajjar, Nawal F Alshehry, Ibraheem H. Motabi, Mohammed S. Alnoamani, Mohammed A. Marei, Mansour Alfayez, Imran K. Tailor

Blood (2021) 138 (Supplement 1): 4532.

https://doi.org/10.1182/blood-2021-152911

Published: 2021

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Erythroblastic sarcoma transformation from chronic myeloid leukaemia: A case report

Conventional Versus Condensed Regimen of High Dose Cytarabine Consolidation in Acute Myeloid Leukemia

Polatuzumab Vedotin As a Salvage Treatment in Relapsed or Refractory DLBCL: Single Center Experience

Safety and Efficacy of Azacitidine with Venetoclax for Newly Diagnosed Intensive Chemotherapy Ineligible, and Relapsed or Refractory Acute Myeloid Leukemia in Arab Population: A Single-Center, Retrospective Study

Efficacy of Brentuximab Vedotin and Bendamustine Combination in Relapsed/Refractory Hodgkin Lymphoma: Experience from a Tertiary Care Hospital

Email alerts

ASH Publications

American Society of Hematology

Update search

Erythroblastic sarcoma transformation from chronic myeloid leukaemia: A case report

Conventional Versus Condensed Regimen of High Dose Cytarabine Consolidation in Acute Myeloid Leukemia

Polatuzumab Vedotin As a Salvage Treatment in Relapsed or Refractory DLBCL: Single Center Experience

Safety and Efficacy of Azacitidine with Venetoclax for Newly Diagnosed Intensive Chemotherapy Ineligible, and Relapsed or Refractory Acute Myeloid Leukemia in Arab Population: A Single-Center, Retrospective Study

Efficacy of Brentuximab Vedotin and Bendamustine Combination in Relapsed/Refractory Hodgkin Lymphoma: Experience from a Tertiary Care Hospital

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only